Table 2. SLE patients and healthy controls included in the intestinal microbiota analysis.
| SLE patients (N = 20) | Healthy controls (N = 20) | |
|---|---|---|
| Sex (female/male) (n) | 20/0 | 20/0 |
| Age (years) | 49.21 ± 10.70 | 46.92 ± 8.63 |
| BMI (Kg/m2) | 26.17 ± 5.34 | 25.20 ± 4.20 |
| Weigth (Kg) | 64.73 ± 11.23 | 67.28 ± 14.03 |
| Blood lipids (mg/dL) | ||
| Total cholesterol | 195.85 ± 37.22 | 198.32 ± 34.34 |
| HDL cholesterol | 64.80 ± 15.52 | 63.00 ± 9.09 |
| LDL cholesterol | 116.35 ± 38.52 | 120,32 ± 31.38 |
| Triglycerides | 71.55 ± 31.02 | 73.73 ± 37.33 |
| Disease parameters | ||
| Age at diagnosis (years) | 38.24 ± 11.85 | |
| Disease duration (years) | 10.40 ± 7.31 | |
| SLEDAI score | 4.83 ± 2.89 | |
| Anti-dsDNA titer (U/ml) | 22.01 ± 30.37 | |
| Treatment, n | ||
| None or NSAIDs | 2 | |
| Antimalarial drugs | 18 | |
Values represent means ± SD. BMI: body mass index; HDL: high-density lipoprotein; LDL: low-density lipoproteins; dsDNA: double stranded DNA; NSAID: non-steroidal anti-inflammatory drug.